Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Novozymes AS | 743 |
| 2 | Novozymes Inc | 666 |
| 3 | Danisco US Inc | 279 |
| 4 | DSM IP Assets BV | 117 |
| 5 | Novozymes North America Inc | 85 |
| 6 | Genzyme Corp | 67 |
| 7 | International N&H Denmark ApS | 60 |
| 8 | Zhejiang University | 60 |
| 9 | Honda Motor Co Ltd | 59 |
| 10 | Protalix Ltd | 47 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | C12N | Microorganisms, enzymes | 2,680 |
| 2 | C12P | Fermentation, enzyme processes | 2,191 |
| 3 | C12Y | Enzyme nomenclature (EC numbers) | 1,941 |
| 4 | Y02E | Climate change mitigation: energy | 1,359 |
| 5 | A61P | Therapeutic activity (drug indications) | 1,153 |
| 6 | A61K | Medicinal preparations | 1,068 |
| 7 | C07K | Peptides | 705 |
| 8 | A23L | Foods and beverages (general) | 648 |
| 9 | A23V | Foods, foodstuffs - indexing scheme | 538 |
| 10 | Y02P | Climate change mitigation: production | 430 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionWho's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Atsuo Kimura | Hokkaido University | 4 |
| 2 | João Atı́lio Jorge | Universidade de São Paulo | 4 |
| 3 | Andreas Pikis | National Institutes of Health | 3 |
| 4 | Dong‐Hyun Kim | Kyung Hee University | 3 |
| 5 | Haruhide Mori | Hokkaido University | 3 |
| 6 | Héctor Francisco Terenzi | Universidade de São Paulo | 3 |
| 7 | John F. Thompson | National Institutes of Health | 3 |
| 8 | Maria de Lourdes Teixeira de Moraes Polizeli | Universidade de São Paulo | 3 |
| 9 | Mikael Bols | Aarhus University | 3 |
| 10 | Rosa dos Prazeres Melo Furriel | Universidade de São Paulo | 3 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Purification and characterization of cellulase produced by Bacillus amyoliquefaciens DL-3 utilizing rice hull | 2007 | 348 | Biofuel production and bioconversion |
| Expression in Trichoderma reesei and characterisation of a thermostable family 3 β-glucosidase from the moderately thermophilic fungus Talaromyces emersonii | 2004 | 157 | Biofuel production and bioconversion |
| Remarkable Supramolecular Catalysis of Glycoside Hydrolysis by a Cyclodextrin Cyanohydrin | 2005 | 120 | Drug Solubulity and Delivery Systems |
| Inhibitory mechanism of morin on α-glucosidase and its anti-glycation properties | 2016 | 119 | Natural Antidiabetic Agents Studies |
| Trehalose-6-phosphate hydrolase of Escherichia coli | 1994 | 118 | Fungal and yeast genetics research |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the chemical composition and molecular weight of p-NPG?
Which organizations hold the most patents involving p-NPG?
What technological areas are most associated with p-NPG patents?
What research topics have been published involving p-NPG?
How has patent activity around p-NPG evolved over recent years?